We further identified that the effects of CYP1A1 knockdown on increased apoptosis in prostate cancer cell lines were correlated with reduction of anti-apoptotic BCL2, the primary gatekeeper of the intrinsic (mitochondrial) apoptotic pathway. Here, BCL2 is linked to prostate cancer.